[HTML][HTML] Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen, M Schnaubelt… - Nature …, 2020 - nature.com
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

[PDF][PDF] Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen, M Schnaubelt, D Clark… - scienovate.com
169 TCGA ovarian tumors from HGSC were analyzed by JHU and PNNL 11. The JHU team
analyzed 119 available ovarian tumors, which were further analyzed using glycoproteomics …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen… - Nature …, 2020 - ui.adsabs.harvard.edu
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

[HTML][HTML] Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen, M Schnaubelt… - Nature …, 2020 - ncbi.nlm.nih.gov
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen… - Nature …, 2020 - econpapers.repec.org
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.

J Pan, Y Hu, S Sun, L Chen… - Nature …, 2020 - search.ebscohost.com
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen… - Nature …, 2020 - pure.johnshopkins.edu
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.

J Pan, Y Hu, S Sun, L Chen, M Schnaubelt… - Nature …, 2020 - europepmc.org
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …

Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer

J Pan, Y Hu, S Sun, L Chen, M Schnaubelt… - Nature …, 2020 - ideas.repec.org
Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-
translational molecular features. To investigate the roles of protein glycosylation in the …